NO20010456L - Triazolopyridiner for behandling av trombose lidelser - Google Patents
Triazolopyridiner for behandling av trombose lidelserInfo
- Publication number
- NO20010456L NO20010456L NO20010456A NO20010456A NO20010456L NO 20010456 L NO20010456 L NO 20010456L NO 20010456 A NO20010456 A NO 20010456A NO 20010456 A NO20010456 A NO 20010456A NO 20010456 L NO20010456 L NO 20010456L
- Authority
- NO
- Norway
- Prior art keywords
- triazolopyridines
- treatment
- thrombosis disorders
- thrombosis
- disorders
- Prior art date
Links
- 208000007536 Thrombosis Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9423198P | 1998-07-27 | 1998-07-27 | |
| US09/354,032 US6303625B1 (en) | 1998-07-27 | 1999-07-15 | Triazolopyridines for the treatment of thrombosis disorders |
| PCT/US1999/016572 WO2000006570A1 (en) | 1998-07-27 | 1999-07-21 | Triazolopyridines for the treatment of thrombosis disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010456D0 NO20010456D0 (no) | 2001-01-26 |
| NO20010456L true NO20010456L (no) | 2001-03-26 |
Family
ID=22243910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010456A NO20010456L (no) | 1998-07-27 | 2001-01-26 | Triazolopyridiner for behandling av trombose lidelser |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6303625B1 (no) |
| EP (1) | EP1102766B1 (no) |
| JP (1) | JP2003527306A (no) |
| KR (1) | KR20010079576A (no) |
| CN (1) | CN1320125A (no) |
| AR (1) | AR019477A1 (no) |
| AT (1) | ATE263169T1 (no) |
| AU (1) | AU757512B2 (no) |
| BR (1) | BR9912556A (no) |
| CA (1) | CA2338654A1 (no) |
| CZ (1) | CZ2001347A3 (no) |
| DE (1) | DE69916073T2 (no) |
| ES (1) | ES2219042T3 (no) |
| HU (1) | HUP0103832A3 (no) |
| ID (1) | ID27214A (no) |
| MX (1) | MXPA01001099A (no) |
| NO (1) | NO20010456L (no) |
| PL (1) | PL345769A1 (no) |
| SK (1) | SK1342001A3 (no) |
| WO (1) | WO2000006570A1 (no) |
| ZA (1) | ZA200100783B (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306909B1 (en) | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| MXPA02001449A (es) * | 1999-08-13 | 2002-07-02 | Biogen Inc | Inhibidores de adhesion de celdas. |
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2002096424A1 (en) * | 2001-05-25 | 2002-12-05 | Queen's University At Kingston | Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| US20090215817A1 (en) * | 2004-08-18 | 2009-08-27 | Pfizer Inc | Novel Triazolopyridine Compounds for the Treatment of Inflammation |
| WO2006052962A2 (en) * | 2004-11-10 | 2006-05-18 | Janssen Pharmaceutica, N.V. | Bicyclic triazole a4 integrin inhibitors |
| EP1925611B1 (en) * | 2005-09-16 | 2016-04-13 | Daiichi Sankyo Company, Limited | Optically active diamine derivative and process for producing the same |
| US7700593B2 (en) * | 2006-10-11 | 2010-04-20 | Amgen Inc. | Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| WO2010117926A1 (en) * | 2009-04-07 | 2010-10-14 | Schering Corporation | Substituted triazolopyridines and analogs thereof |
| US8871760B2 (en) * | 2009-09-21 | 2014-10-28 | Roche Palo Alto Llc | [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators |
| EA026655B1 (ru) | 2011-09-15 | 2017-05-31 | Новартис Аг | 6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ |
| CA2914040A1 (en) * | 2013-06-03 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic diseases |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050525A (en) | 1960-12-14 | 1962-08-21 | John B Bicking | Certain derivatives of s-triazolo [4, 3-a]-pyridine |
| CA2155123A1 (en) | 1993-02-22 | 1994-09-01 | David Alan Claremon | Fibrinogen receptor antagonists |
| DE4326758A1 (de) * | 1993-08-10 | 1995-02-16 | Basf Ag | [1,3,4]Triazolo[1,5-a]pyridine |
| CA2134192A1 (en) | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
-
1999
- 1999-07-15 US US09/354,032 patent/US6303625B1/en not_active Expired - Lifetime
- 1999-07-21 EP EP99937373A patent/EP1102766B1/en not_active Expired - Lifetime
- 1999-07-21 SK SK134-2001A patent/SK1342001A3/sk unknown
- 1999-07-21 MX MXPA01001099A patent/MXPA01001099A/es unknown
- 1999-07-21 DE DE69916073T patent/DE69916073T2/de not_active Expired - Fee Related
- 1999-07-21 KR KR1020017001183A patent/KR20010079576A/ko not_active Withdrawn
- 1999-07-21 CN CN99811380A patent/CN1320125A/zh active Pending
- 1999-07-21 JP JP2000562372A patent/JP2003527306A/ja active Pending
- 1999-07-21 HU HU0103832A patent/HUP0103832A3/hu unknown
- 1999-07-21 CZ CZ2001347A patent/CZ2001347A3/cs unknown
- 1999-07-21 AT AT99937373T patent/ATE263169T1/de not_active IP Right Cessation
- 1999-07-21 CA CA002338654A patent/CA2338654A1/en not_active Abandoned
- 1999-07-21 ID IDW20010365A patent/ID27214A/id unknown
- 1999-07-21 AU AU52218/99A patent/AU757512B2/en not_active Ceased
- 1999-07-21 ES ES99937373T patent/ES2219042T3/es not_active Expired - Lifetime
- 1999-07-21 WO PCT/US1999/016572 patent/WO2000006570A1/en not_active Ceased
- 1999-07-21 PL PL99345769A patent/PL345769A1/xx not_active Application Discontinuation
- 1999-07-21 BR BR9912556-0A patent/BR9912556A/pt not_active Application Discontinuation
- 1999-07-26 AR ARP990103671A patent/AR019477A1/es unknown
-
2001
- 2001-01-26 ZA ZA200100783A patent/ZA200100783B/en unknown
- 2001-01-26 NO NO20010456A patent/NO20010456L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE263169T1 (de) | 2004-04-15 |
| BR9912556A (pt) | 2002-01-15 |
| JP2003527306A (ja) | 2003-09-16 |
| ID27214A (id) | 2001-03-08 |
| PL345769A1 (en) | 2002-01-02 |
| ES2219042T3 (es) | 2004-11-16 |
| CA2338654A1 (en) | 2000-02-10 |
| KR20010079576A (ko) | 2001-08-22 |
| HUP0103832A2 (hu) | 2002-04-29 |
| AU5221899A (en) | 2000-02-21 |
| WO2000006570A1 (en) | 2000-02-10 |
| AU757512B2 (en) | 2003-02-20 |
| SK1342001A3 (en) | 2002-04-04 |
| EP1102766B1 (en) | 2004-03-31 |
| DE69916073T2 (de) | 2004-12-30 |
| DE69916073D1 (de) | 2004-05-06 |
| CN1320125A (zh) | 2001-10-31 |
| AR019477A1 (es) | 2002-02-20 |
| ZA200100783B (en) | 2002-01-28 |
| MXPA01001099A (es) | 2002-04-24 |
| US6303625B1 (en) | 2001-10-16 |
| EP1102766A1 (en) | 2001-05-30 |
| NO20010456D0 (no) | 2001-01-26 |
| HUP0103832A3 (en) | 2002-12-28 |
| CZ2001347A3 (cs) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983284D0 (no) | Antikoagolante midler egnet i behandling av trombose | |
| NO993051D0 (no) | Intranasale formuleringer for behandling av seksuelle forstyrrelser | |
| NO20005884L (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| NO996483L (no) | Imidasopyrimidiner og imidasopyridiner for behandling av neurologiske lidelser | |
| NO20012160D0 (no) | Anordning for behandling av makulös degenerering | |
| NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
| NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
| NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
| NO20005885L (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
| NO20003042L (no) | FremgangsmÕte for profylaktisk behandling av mastitt | |
| NO20010456L (no) | Triazolopyridiner for behandling av trombose lidelser | |
| NO20003454D0 (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
| NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| NO991460D0 (no) | Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt | |
| NO20011892L (no) | 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser | |
| NO974569D0 (no) | Benzamider for behandling av neurodegenerative forstyrrelser | |
| NO20010390D0 (no) | Behandling av angstsykdommer | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| IS6098A (is) | Ósantant til meðhöndlunar á skaptruflunum | |
| NO984189D0 (no) | Fremgangsmåte for behandling av bipolar forstyrrelse | |
| NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
| NO952411D0 (no) | Midler for behandling av metaboliske bensykdommer | |
| NO962812D0 (no) | Fremgangsmåte for behandling av nervebetennelse | |
| IL141129A0 (en) | Triazolopyridines for the treatment of thrombosis disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |